L. Alberio

Discipline

Psychologie (6) Sociologie (2) Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (40) Recensions (13)

Co-auteur

Date

Source

Mot-clé

Patients (24) Patients (24) Human beings (16) Treatment (15) puits (12) Hemorrhage (11) risque (10) Risk (10) Management (10) Management (10) gestion (9) laboratoire (9) Practice (9) thérapie (8) Diagnosis (8) Case (8) Ci (Chinese poetry) (8) Thrombosis (8) Therapeutics (8) Grammar, Comparative and general--Case (8) Case (8) Thrombocytopenia (7) Thrombin (7) Fibrinogen (7) Diagnosis (7) Blood platelets (7) Older people (7) plasma (7) analyse (6) analyse (6)

Documents écrit par L. Alberio (40) | parle de L. Alberio (0)

Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure.
L. Schönborn et al. (28 déc. 2023)
Bilan hématologique en cas de fausses couches précoces à répétition : quelles évidences ? [Hematological workup in cases of recurrent early miscarriages: what evidences?]
D. Choffat et al. (18 oct. 2023)
Successful outcome of pregnancy post-allogeneic stem cell transplant despite severe RH1 alloimmunization: A case report.
M. Gavillet et al.
Long-Term Consequences of COVID-19: A 1-Year Analysis.
L. Bamps et al. (3 avr. 2023)
Caplacizumab for treating subacute intra-stent thrombus occurring despite efficacious double anti-platelet treatment and anticoagulation: a case report.
G. Stalder et al.
How to Solve the Conundrum of Heparin-Induced Thrombocytopenia during Cardiopulmonary Bypass.
E. Revelly et al. (18 janv. 2023)
Pseudoreticulocytosis in a patient with myelodysplastic syndrome.
N. De Rossi et al. (1 juin 2022)
Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia.
M. Marchetti et al.
Another piece of knowledge in the puzzle of procoagulant COAT platelets.
A. Aliotta et al.
Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP.
A. Segot et al.
EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders.
L. Veloza et al.
Mechanisms Underlying Dichotomous Procoagulant COAT Platelet Generation-A Conceptual Review Summarizing Current Knowledge.
L. Veuthey et al. (25 févr. 2022)
Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study.
T. Meihandoest et al. (2022)
Maladie thromboembolique veineuse et grossesse : diagnostic, traitement et suivi [Venous thromboembolic disease during pregnancy : diagnosis, treatment and follow-up]
M. Vecchio et al. (8 déc. 2021)
A universal anti-Xa assay for rivaroxaban, apixaban, and edoxaban measurements: method validation, diagnostic accuracy and external validation.
G. Willekens et al.
Vitamine B12 en pratique : quand tester ? Comment tester ? Et qui substituer ? [Vitamin B12 in practice: When to test ? How to test ? And who should be treated?]
J.P. Bruttin et al. (24 mars 2021)
Thrombocytopathies: Not Just Aggregation Defects-The Clinical Relevance of Procoagulant Platelets.
A. Aliotta et al. (24 févr. 2021)
Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management.
M. Marchetti et al. (10 févr. 2021)
Automated Thrombin Generation Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements.
T. Meihandoest et al. (2021)
Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider.
D. Solari et al.
Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab.
P. Fontana et al. (14 déc. 2020)
Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia.
A. Aliotta et al. (14 déc. 2020)
Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis.
M. Fraga et al.
Utility of the Platelet Function Analyzer in Patients with Suspected Platelet Function Disorders: Diagnostic Accuracy Study.
J. Kaufmann et al.
Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient.
G. Stalder et al. (13 août 2020)

next